PATENT CLAIM ANALYSIS

Application Number: 16247132
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-08
Patent Classification: ["546", "113000"]

Abstract:
The present invention relates to compounds of the formula (I), or pharmaceutically acceptable salts, enantiomer or diastereomer thereof, wherein R 1  to R 5  are as described above. The compounds may be useful for the treatment or prophylaxis of hepatitis B virus infection.

Claim (Index 5):
A process for preparing a compound according to  claim 1  comprising any one of the following steps:\n (a) the reaction of iodide (IV), \n with R 6 R 7 NH in the presence of a copper catalyst; (b) the reaction of iodide (IV), with boronic acid R 1 \u2014B(OH) 2  in the presence of a palladium catalyst; (c) the reaction of a compound of formula (VI), with a base followed by coupling with R 3 NH 2  in the presence of a coupling reagent; wherein R 2 , R 3 , R 4 , R 5  are defined as in  claim 1 ; and R 8  is aryl, heteroaryl or C 3-7 cycloalkyl.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 99.0
- Lexical Diversity: 1.28205
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14997346', '16247170', '16196324', '16247084', '14632078']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7884485037961677
- 35 USC 102 Novelty (BERT): 0.5664329474857887
- Combined Prediction Score: 0.7662469481651298
- Mean Citation Score: 415.54647000000006
- Max Citation Score: 473.76462
- Similarity Product: 351.19179483219267

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test